Articles From: Two-Thirds of Parents Wish They Spent More Time Teaching Their Teen to Drive in High-Risk Situations to GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma


2013/3/15
More than half of teens say they want more time behind the wheel with their parents Drive it Home™ launched by The Allstate Foundation and National Safety Council offers unique, life-saving approaches for parents NORTHBROOK, Ill.
Sign-up for Two-Thirds of Parents Wish They Spent More Time Teaching Their Teen to Drive in High-Risk Situations investment picks
2013/3/15
Family Health Centers of San Diego has been awarded a $505,000 grant by UnitedHealthcare to help improve health care delivery services for local patients and community residents.
Sign-up for UnitedHealthcare Awards $5.2 Million in Grants to California Nonprofits – $505,000 to Family Health Centers of San Diego investment picks
2013/3/15
BENTON HARBOR, Mich.
Sign-up for Whirlpool Corporation appoints Esther Berrozpe president of Europe, Middle East and Africa investment picks
2013/3/15
Wipro Technologies, the Global Information Technology, Consulting and Outsourcing business of Wipro Ltd.
Sign-up for Wipro Appraised at CMMI-DEV V1.3 Level 5 investment picks
2013/3/15
Currency-Hedged Japan Fund Rakes in Highest Year-to-Date Inflows in U.S. ETF Market 1 NEW YORK, March 15, 2013 (GLOBE NEWSWIRE) -- WisdomTree (Nasdaq:WETF) , an exchange-traded fund ("ETF") sponsor and asset manager, today announced the WisdomTree Japan Hedged Equity Fund (DXJ) recently surpassed $5 billion in assets.
Sign-up for WisdomTree Japan Hedged Equity Fund (DXJ) Surpasses $5 Billion in Assets investment picks
2013/3/15
BEIJING, March 15, 2013 (GLOBE NEWSWIRE) -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), the largest carrier-neutral Internet data center services provider in China, today announced that the Company has priced the offering of RMB1 billion (approximately equivalent to US$160.9 million 1 ) in aggregate principal amount of bonds due 2016 with a coupon rate of 7.875% per annum (the "Bonds"). The Bonds are denominated in RMB and are being offered outside the United States in reliance on Regulation S under the Securities Act of 1933, as amended.
Sign-up for 21Vianet Group, Inc. Announces the Pricing of RMB1 Billion Bonds investment picks
2013/3/14
PHILADELPHIA , March 14, 2013 /PRNewswire/ --  Aberdeen Emerging Markets Telecommunications and Infrastructure Fund, Inc. (NYSE MKT: ETF) (the "Fund") today announced that its shareholders have voted in the affirmative along with the Board of Directors to change certain investment policies of the Fund.
Sign-up for Aberdeen Emerging Markets Telecommunications and Infrastructure Fund, Inc. Announces Results of Special Meeting of Shareholders and Approval of Change to Name and Investment Policies investment picks
2013/3/14
SAN DIEGO, March 14, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (Nasdaq:APRI) ( www.apricusbio.com ) today announced that it intends to cease financing its French subsidiaries, Finesco SAS, its French holding company, Scomedica SAS, its French sales company and NexMed Pharma SAS its marketing company.
Sign-up for Apricus Biosciences Announces Ceasing of Financing of French Subsidiaries investment picks
2013/3/14
Although the $1.2 billion super-premium vodka market in the U.S. keeps on growing every day, the stiff competition for vodka-drinkers’ dollars leaves many emerging producers badly in need of a drink.
Sign-up for ASCC Lays Foundation to Repeat Tito’s All-American Success Story investment picks
2013/3/14
Ascent Capital Group, Inc. (“Ascent” or the “Company”) (Nasdaq: ASCMA) will be holding its Annual Meeting of Shareholders on Wednesday, May 22, 2013 at 10:00 a.m., Mountain Time at 5251 DTC Parkway, Greenwood Village, Colorado 80111 ( the meeting will be held in the Second Floor Conference Room). The record date for the meeting is 5:00 p.m., New York City time, on April 3, 2013.
Sign-up for Ascent Capital Group, Inc. to Hold Annual Meeting of Shareholders investment picks
2013/3/14
http://media.marketwire.com/attachments/201106/73096_Logo-ALCwithColoredSwan.JPG http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=996280&ProfileId=051205&sourceType=1 MENOMONEE FALLS, WI --
Sign-up for Assisted Living Concepts, Inc. Announces Fourth Quarter Results investment picks
2013/3/14
At SXSW, Domtar Unveils New, Cutting Edge 'Paper Hotspot' Canada NewsWire Say Hello (Again) to Paper - the Original, Wireless, Interactive Communications Platform; It Offered an Unplugged, Interactive Respite at One of the World's Largest Interactive Festivals TICKER SYMBOL (NYSE: UFS) (TSX: UFS) MONTREAL , March 14, 2013 /CNW Telbec/ - The SXSW Interactive Festival describes itself as "an incubator of cutting-edge technologies and digital creativity," and at the 20 th annual show, Domtar Corporation unveiled a wireless venue that made people halt, spurred them to step inside and quickly became one of the most popular features: the Paper Hotspot .
Sign-up for At SXSW, Domtar Unveils New, Cutting Edge 'Paper Hotspot' investment picks
2013/3/14
Bank of America today announced that the company’s Board of Directors authorized the repurchase of up to $5.0 billion of common stock and the redemption of approximately $5.5 billion in preferred stock.
Sign-up for Bank of America Plans to Repurchase up to $5 Billion in Common Shares and Redeem Approximately $5.5 Billion in Preferred Stock investment picks
2013/3/14
SYNNEX Canada Limited , a wholly-owned subsidiary of SYNNEX Corporation (NYSE: SNX) , a leading distributor of IT and consumer electronics products and services, has been selected by Beats by Dr.
Sign-up for Beats by Dr. Dre Selects SYNNEX Canada as Its Exclusive Canadian Distributor to Expand Its Collection of Authentic, High-End Audio Products in the Retail Channel investment picks
2013/3/14
Belden Inc. (NYSE: BDC) , a global leader in signal transmission solutions for mission critical applications, today announced the pricing of its private offering of €300 million in aggregate principal amount of 5.5% senior subordinated notes due 2023 at an issue price of 100% of the principal amount.
Sign-up for Belden Announces Pricing of €300 Million Private Offering of 5.5% Senior Subordinated Notes investment picks
2013/3/14
NEW YORK , March 14, 2013 /PRNewswire/ -- BNY Mellon, the global leader in investment management and investment services, has announced a number of new senior management appointments as the company enhances its presence and capabilities in the Investment Services space around the world.
Sign-up for BNY Mellon Announces New Senior Investment Services Leadership Roles investment picks
2013/3/14
SAN DIEGO , March 14, 2013 /PRNewswire/ -- Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) , a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today the appointment of Stephen L.
Sign-up for Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors investment picks
2013/3/14
Chesapeake Lodging Trust (NYSE: CHSP) (the "Trust") announced today that it has closed on the previously announced acquisition of the newly developed, 185-room Hyatt Place New York Midtown South located in New York, New York for a purchase price of $76.2 million, or approximately $412,000 per key.
Sign-up for Chesapeake Lodging Trust Acquires Hyatt Place New York Midtown South investment picks
2013/3/14
Citigroup today announced that the Federal Reserve Board (FRB) has advised Citi that it has no objection to the planned capital actions requested by Citi as part of the 2013 Comprehensive Capital Analysis and Review (CCAR). The planned capital actions include a $1.2 billion common stock buyback program through the first quarter of 2014 and the maintenance of current common stock dividends ($0.01 per share per quarter). Any repurchases of common stock and common stock dividends remain subject to approval by Citigroup’s Board of Directors.
Sign-up for Citi Statement on 2013 CCAR Planned Capital Actions investment picks
2013/3/14
BURLINGTON, Mass., March 14, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) , a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today its financial results for the fourth quarter and year ended December 31, 2012.
Sign-up for Coronado Biosciences Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2012 investment picks
2013/3/14
Upgrade Will Enable More than 700 Users to Access and Analyze Content in ASG's ViewDirect Archiving Platform with the Industry's Most Robust Information Optimization Solution from Datawatch CHELMSFORD, Mass.
Sign-up for Datawatch Replaces ASG Software Solutions' DocuAnalyzer with Monarch Professional at One of the World's Largest Financial Institutions investment picks
2013/3/14
Derma Sciences, Inc. (the “Company”) (Nasdaq: DSCI) , a medical device and pharmaceutical company focused on advanced wound care, announced today that the Company will be presenting at the 25 th Annual ROTH Conference on Tuesday, March 19 at 12:00 p.m. Pacific Time.
Sign-up for Derma Sciences to Present at the 25th Annual ROTH Conference investment picks
2013/3/14
The directors and officers (D&O) liability insurance marketplace is in a state of transition, characterized by a firming market, according to the 2012 Directors and Officers Liability Survey conducted by global professional services company Towers Watson (NYSE, NASDAQ: TW). The survey found the market shift was most evident in the private/not-for-profit space, where 41% of respondents reported an increase to their primary D&O policy premium, up from 18% in 2011.
Sign-up for Directors and Officers Liability Insurance Market Firming investment picks
2013/3/14
The Dow Chemical Company (NYSE: DOW) today announced additional actions to accelerate the Company’s ongoing commitment to aggressive portfolio management, as outlined at its Investor Forum in December 2012.
Sign-up for Dow Accelerates Portfolio Management Actions to Divest Non-Core Businesses; Targets More Than $1 Billion in Proceeds investment picks
2013/3/14
WASHINGTON , March 14, 2013 /PRNewswire/ -- Fannie Mae (OTC Bulletin Board: FNMA) priced its third Multifamily DUS ® REMIC in 2013 totaling $904.3 million under its Fannie Mae Guaranteed Multifamily Structures (Fannie Mae GeMS) program on March 13, 2013 .
Sign-up for Fannie Mae Prices $904.3 Million Multifamily DUS REMIC (FNA 2013-M4) Under Its Fannie Mae GeMS™ Program investment picks
2013/3/14
Significant milestone for project vital to Georgia's energy future ATLANTA , March 14, 2013 /PRNewswire/ -- Georgia Power has completed the placement of basemat structural concrete for the nuclear island at its Vogtle Unit 3 nuclear expansion site, a significant achievement in the building of the first new nuclear units in the United States in 30 years.
Sign-up for First nuclear concrete placed at Plant Vogtle expansion investment picks
2013/3/14
HOUSTON , March 14, 2013 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") today announced that the Company's Board of Directors has elected H.
Sign-up for Flotek Industries Announces Appointment of H. Richard Walton as Chief Financial Officer investment picks
2013/3/14
HOUSTON and MUSCAT , Sultanate of Oman , March 14, 2013 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") announced this morning the execution of a Letter of Intent (the "Agreement") with an affiliate of Gulf Energy, LLC ("Gulf Energy"), a leading Oman -based diversified oil and gas concern, to construct an advanced oilfield chemistry production facility and create a state-of-the-art research and development organization to address the growing need for advanced oilfield chemistry and analysis in the Middle East and North Africa .
Sign-up for Flotek Industries, Inc. Announces Letter of Intent with Gulf Energy, LLC to Develop Advanced Oilfield Chemistry Production and Research & Development Facilities in Sultanate of Oman investment picks
2013/3/14
LAKE OSWEGO, Ore., March 14, 2013 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq:GALE) , a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that independent research firm, Frost & Sullivan, has recognized Galena Biopharma with the 2013 Global Frost & Sullivan Award for New Product Innovation.
Sign-up for Galena Biopharma Receives 2013 Global Frost & Sullivan Award for New Product Innovation for NeuVax(TM) investment picks
2013/3/14
GenSpera, Inc. (OTCBB:GNSZ) announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted Orphan Drug Designation to its lead candidate, G-202, for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer.
Sign-up for GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Two-Thirds of Parents Wish They Spent More Time Teaching Their Teen to Drive in High-Risk Situations to GenSpera’s G-202 Granted U.S. Orphan Drug Designation for Treatment of Hepatocellular Carcinoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity